Stanger O - Search Results

1

Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.

Stühlinger MC, Stanger O. Stühlinger MC, et al. Among authors: stanger o. Curr Drug Metab. 2005 Feb;6(1):3-14. doi: 10.2174/1389200052997393. Curr Drug Metab. 2005. PMID: 15720202 Review.

2

Physiology of folic acid in health and disease.

Stanger O. Stanger O. Curr Drug Metab. 2002 Apr;3(2):211-23. doi: 10.2174/1389200024605163. Curr Drug Metab. 2002. PMID: 12003352 Review.

3

Increased asymmetric dimethylarginine concentrations in stimulated peripheral blood mononuclear cells.

Schroecksnadel K, Weiss G, Stanger O, Teerlink T, Fuchs D. Schroecksnadel K, et al. Among authors: stanger o. Scand J Immunol. 2007 Jun;65(6):525-9. doi: 10.1111/j.1365-3083.2007.01935.x. Scand J Immunol. 2007. PMID: 17523944 Free article.

4

Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.

Stanger O, Weger M. Stanger O, et al. Clin Chem Lab Med. 2003 Nov;41(11):1444-54. doi: 10.1515/CCLM.2003.222. Clin Chem Lab Med. 2003. PMID: 14656024 Review.

5

Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.

Stanger O, Weger M, Renner W, Konetschny R. Stanger O, et al. Clin Chem Lab Med. 2001 Aug;39(8):725-33. doi: 10.1515/CCLM.2001.121. Clin Chem Lab Med. 2001. PMID: 11592442 Review.

6

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M; DACH-LIGA Homocystein e.V. Stanger O, et al. Clin Chem Lab Med. 2003 Nov;41(11):1392-403. doi: 10.1515/CCLM.2003.214. Clin Chem Lab Med. 2003. PMID: 14656016 Review.

7

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.

Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A. Weger M, et al. Among authors: stanger o. Graefes Arch Clin Exp Ophthalmol. 2002 Apr;240(4):286-90. doi: 10.1007/s00417-002-0431-9. Epub 2002 Feb 21. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 11981642

8

Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.

Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Quehenberger F, Semmelrock J, Haas A. Weger M, et al. Among authors: stanger o. Ophthalmology. 2002 Jun;109(6):1105-9. doi: 10.1016/s0161-6420(02)01044-8. Ophthalmology. 2002. PMID: 12045051

9

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. Stanger O, et al. Z Kardiol. 2004 Jun;93(6):439-53. doi: 10.1007/s00392-004-0075-3. Z Kardiol. 2004. PMID: 15252738 Review.

10

Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.

Stanger OH, Semmelrock HJ, Rehak P, Tiran B, Meinitzer A, Rigler B, Tiran A. Stanger OH, et al. Atherosclerosis. 2002 May;162(1):157-62. doi: 10.1016/s0021-9150(01)00686-4. Atherosclerosis. 2002. PMID: 11947909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters